IRIS Institutional Research Information System - OPENBS Open Archive UniBS

REGOLA, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 875
AS - Asia 695
EU - Europa 525
SA - Sud America 127
OC - Oceania 24
AF - Africa 20
Totale 2.266
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 854
SG - Singapore 272
CN - Cina 171
IT - Italia 155
DE - Germania 103
BR - Brasile 100
HK - Hong Kong 90
VN - Vietnam 61
FI - Finlandia 55
FR - Francia 37
GB - Regno Unito 34
UA - Ucraina 32
RU - Federazione Russa 24
AU - Australia 23
TR - Turchia 17
IE - Irlanda 16
IN - India 16
NL - Olanda 14
BD - Bangladesh 12
AR - Argentina 11
CA - Canada 11
SE - Svezia 11
JP - Giappone 10
GR - Grecia 9
IQ - Iraq 8
MX - Messico 8
PK - Pakistan 8
AT - Austria 7
EG - Egitto 7
MK - Macedonia 7
PL - Polonia 6
CO - Colombia 5
ES - Italia 5
PH - Filippine 4
TH - Thailandia 4
TN - Tunisia 4
CH - Svizzera 3
EC - Ecuador 3
JO - Giordania 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
CL - Cile 2
ET - Etiopia 2
IR - Iran 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
UG - Uganda 2
UZ - Uzbekistan 2
VE - Venezuela 2
ZA - Sudafrica 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
GE - Georgia 1
HN - Honduras 1
HU - Ungheria 1
ID - Indonesia 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
MA - Marocco 1
NZ - Nuova Zelanda 1
PE - Perù 1
PS - Palestinian Territory 1
SR - Suriname 1
SV - El Salvador 1
TW - Taiwan 1
Totale 2.266
Salva come PNG Salva come JPEG
Città #
Singapore 162
Ashburn 99
Hong Kong 87
San Jose 67
Fairfield 65
Beijing 50
Helsinki 42
The Dalles 38
New York 37
Munich 31
Chandler 30
Los Angeles 29
Brescia 28
Houston 27
Jacksonville 25
Princeton 25
Woodbridge 23
Cambridge 22
Ho Chi Minh City 22
Wilmington 22
Seattle 21
Dallas 20
Lauterbourg 16
Milan 16
Ann Arbor 15
Dublin 15
Hanoi 15
Sydney 14
Istanbul 13
Buffalo 11
Turku 11
Council Bluffs 10
Orem 10
Rome 10
San Francisco 9
Brooklyn 8
San Diego 8
São Paulo 8
Athens 7
Chicago 7
Montreal 7
Shanghai 7
Stockholm 7
Amsterdam 6
Bergamo 6
Cairo 6
Nuremberg 6
Redondo Beach 6
Baghdad 5
Frankfurt am Main 5
Melbourne 5
Mexico City 5
Rho 5
Adelaide 4
Bosio 4
Changsha 4
Des Moines 4
Dosso 4
Louisville 4
Moscow 4
Porto Alegre 4
Rawalpindi 4
Santa Clara 4
Tokyo 4
Amman 3
Atlanta 3
Brasília 3
Catania 3
City of London 3
Curitiba 3
Denver 3
Dhaka 3
Duncan 3
Falkenstein 3
Gothenburg 3
London 3
Lucknow 3
Manchester 3
Redwood City 3
Shenyang 3
Skopje 3
Toledo 3
Abu Dhabi 2
Addis Ababa 2
Bagheria 2
Bangkok 2
Bauru 2
Belo Horizonte 2
Bengaluru 2
Biên Hòa 2
Bratislava 2
Buenos Aires 2
Corte Franca 2
Cosenza 2
Cuenca 2
Genoa 2
Haikou 2
Haiphong 2
Hampton 2
Hyderabad 2
Totale 1.385
Salva come PNG Salva come JPEG
Nome #
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study 215
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy 200
Effector T-cells are expanded in systemic lupus erythematosus patients with high disease activity and damage indexes 187
Association Between Changes in BLyS Levels and the Composition of B and T Cell Compartments in Patients With Refractory Systemic Lupus Erythematosus Treated With Belimumab 169
DEVELOPMENT OF NEW PERSONALIZED DIAGNOSTIC AND THERAPEUTIC STRATEGIES IN GIANT CELL ARTERITIS: IDENTIFICATION OF NEW MARKERS FOR DISEASE SUBSETS AND PREDICTORS OF THERAPEUTIC RESPONSE 167
Circulating follicular helper T cells (CD4+CXCR5+ICOS+) decrease in patients with rheumatoid arthritis treated with abatacept 138
Characterization of B- and T-Cell Compartment and B-Cell Related Factors Belonging to the TNF/TNFR Superfamily in Patients With Clinically Active Systemic Lupus Erythematosus: Baseline BAFF Serum Levels Are the Strongest Predictor of Response to Belimumab after Twelve Months of Therapy. 137
Long-term treatment with tocilizumab in giant cell arteritis: efficacy and safety in a monocentric cohort of patients 134
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting 115
Can we use NOACS in APS? 93
CXCL-13 serum levels in patients with rheumatoid arthritis treated with abatacept 93
Pregnancy in antiphospholipid syndrome: what should a rheumatologist know? 91
Retinal microvascular alterations in patients with active rheumatoid arthritis without cardiovascular risk factors: the potential effects of T cell co-stimulation blockade 89
Retinal microvascular alterations in patients with active rheumatoid arthritis without cardiovascular risk factors: the potential effects of T cell co-stimulation blockade 83
Novel Therapies in Takayasu Arteritis. 78
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort 74
Novel Targets for Drug Use in Eosinophilic Granulomatosis With Polyangiitis 73
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study-Joint and Skin (BeRLiSS-JS) 69
Tapering belimumab in patients with systemic lupus erythematosus: a single-centre experience 61
The use of tumor necrosis factor inhibitors during high-risk pregnancies in antiphospholipid syndrome: a clinical report of a patient with concomitant Takayasu arteritis and case-based review 26
Totale 2.292
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.462
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.462
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218 0 0 0 0 0 0 0 0 0 0 0 8
2021/2022133 9 16 10 4 4 6 5 11 7 15 21 25
2022/202393 15 1 3 5 10 29 0 10 11 0 6 3
2023/2024162 13 3 21 14 5 30 3 16 35 1 5 16
2024/2025535 7 13 8 51 28 38 68 23 29 66 130 74
2025/20261.005 94 118 70 144 105 75 142 44 80 84 35 14
Totale 2.292